The subject of marijuana and exactly what its primary active ingredient, THC, can do have actually long been disputed in the political and clinical communities, however, it was difficult to argue with National Cancer Institute research and video footage that shows marijuana’s abilities to kill cancer cells.
In reality, the very first experiment recording pot’s powerful anti-cancer impacts happened in 1974 at the Medical College of Virginia at the request federal bureaucrats. The outcomes of that study, was released in a feature article in the Washington Post paper on August 18, 1974. Were that marijuana’s main psychoactive component, THC, “slowed the growth of lung cancers, breast cancers and virus-induced leukemia in laboratory mice, and prolonged their lives by as much as 36 percent.”
After the revelation of this particular research study, more studies started turning up that supported this conclusion.
A 1975 research study published in the Journal of the National Cancer Institute specified that “Lewis lung adenocarcinoma development was slowed down by the oral administration of tetrahydrocannabinol (THC) and cannabinol (CBD). Mice dealt with for 20 successive days with THC and CBD had actually lowered initial growth size.”
The War On Drugs, stated by President Nixon in 1971, has actually prevented a considerable quantity of research study into THC can significantly impact the size of tumors growths and amount of cancer cells in a person’s body.
A number of research studies from the last twenty years have actually shown that THC can in fact utterly destroy cancer cells, and the SETH group specified,
Have any preclinical (laboratory or animal) research studies been conducted utilizing cannabinoids or cannabis?
Preclinical research studies of cannabinoids have actually examined the following antitumor activity:
- Research studies in rats and mice have shown that cannabinoids may prevent tumor growth by causing cell death, blocking cell growth, and obstruct the development of blood vessels needed by tumors to grow.
- Laboratory and animal research studies have shown that cannabinoids may be able to eliminate cancer cells while safeguarding healthy cells
- A study in mice demonstrated that cannabinoids might protect against inflammation of the colon and might have potential in decreasing the risk of colon cancer, and potentially in its treatment
- A laboratory study of delta-9-THC in hepatocellular carcinoma (liver cancer) cells showed that it damaged or killed the cancer cells. The exact same survey of delta-9-THC in mouse models of liver cancer revealed that it had antitumor results. Delta-9-THC has actually been shown to trigger these effects by acting upon molecules that might likewise be found in non-small breast cell cancer cells and lung cancer cells.
A laboratory research study of cannabidiol (CBD) in estrogen receptor favorable and estrogen receptor unfavorable breast cancer cells revealed that it triggered cancer cell death while having little impact on healthy breast cells. Research studies in mouse models of metastatic breast cancer demonstrated that cannabinoids might lessen the growth, number, and spread of tumors.
A laboratory research study of cannabidiol (CBD) in human glioma* cells revealed that when given along with chemotherapy, CBD may make chemotherapy more effective and increase cancer cell death without harming normal cells. Studies in mouse models of cancer showed that CBD together with delta-9-THC might make chemotherapy such as temozolomide more efficient.
*gliomas — a highly aggressive form of malignant brain tumors that kills approximately 13,000 Americans every year – about 2% of all U.S. cancer deaths. Tragically claim the lives of 75 percent of its victims within two years and virtually all within five years. About 55% of these deaths are men.
Watch the short video below that shows what happens when THC efficient into cancer cells.